Business Context and Reporting Period
This Form 6-K filing by Brainsway Ltd. covers the month of November 2019. The report documents the outcomes of a Special General Meeting of Shareholders held on November 25, 2019, where all proposed resolutions were approved.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and shareholder resolutions rather than financial performance data.
Material Changes
The filing details three material corporate actions approved by shareholders:
- Appointment of Dr. David Zacut, Chairman of the Board, as interim Chief Executive Officer for a term of up to one year, with a corresponding increase in his consultancy capacity.
- Amendment to the Company's Articles of Association regarding the office of directors appointed by the Board.
- Approval of the Brainsway Ltd. Amended and Restated 2019 Share Incentive Plan.
Guidance, Outlook, and Risks
The filing does not contain management commentary on future guidance, market outlook, specific risks, contingencies, or unusual items. The document serves strictly to disclose the shareholder approvals listed above.
Investor Verification Checklist
- Verify the effective start date and specific compensation terms for Dr. David Zacut's interim CEO role.
- Review the specific language of the amendment to the Articles of Association regarding director appointments.
- Examine the details of the Amended and Restated 2019 Share Incentive Plan for potential dilution impacts.